Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
92 /100
CRITICAL RISK
Score updated Oct 13, 2026

MBRX — Moleculin Biotech, Inc. Dilution Risk Tracker

Track MBRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MBRX — Get alerts when the score changes →

As of October 13, 2026, Moleculin Biotech, Inc. (MBRX) has a DilutionWatch DilutionScore of 92/100, rated CRITICAL dilution risk. Moleculin Biotech, Inc. has a market capitalization of $8.18M, 19.48M shares outstanding, 3 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $15.30M, 7.60M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
85
📊 Float Risk
80
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 48%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 39% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 53%
• Low cash runway: 4 months remaining
• Active ATM program with $15M remaining capacity
🔄 Reverse Split model est. 15%
• Only 4 months cash — financial pressure
🔔 Track MBRX — Get forecast alerts →

Market Data

Market Cap$8.18M
Shares Outstanding19.48M
Float5.29M
Cash$7.26M
Debt$326.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore92/100DilutionWatch score record
Shares Outstanding19.48MVerified float table or market cache
Public Float5.29MVerified float table or market cache
Market Cap$8.18MMarket data cache
Cash Runway3.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$15.30MSEC-derived dilution fields
Outstanding Warrants7.60MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 3, 8-K 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 378.2% shares (2026Q1 vs prior)
3 institutional holders · 1.3K shares
#1 MORGAN STANLEY 926 shares
#2 BARCLAYS PLC 344 shares
#3 DANSKE BANK A/S 2 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest204.6K
Days to Cover1.0
% of Float3.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-18
xbrl XBRL CONVERTIBLE 2019-02-21
8-K 8K EVENT 2026-06-30
4 INSIDER TRANSACTION 2026-06-24
4 INSIDER TRANSACTION 2026-06-24
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual MBRX Dilution Snapshot

Moleculin Biotech, Inc. (MBRX) has a DilutionScore of 92/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

MBRX's DilutionScore is currently 92/100 (Critical risk), with 4 score changes tracked over 89 days. The score improved from 79/100 (Critical risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202692/100CRITICAL13 days
Sep 21 – Sep 30, 202679/100CRITICAL10 days
Aug 22 – Sep 20, 202680/100CRITICAL30 days
Aug 14 – Aug 21, 202675/100HIGH7 days
Jul 16 – Aug 13, 202673/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track MBRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MBRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MBRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MBRX
MBRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.